enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

   www.aol.com/news/boehringer-cut-pocket-costs...

   The company has cut out-of-pocket costs for its full range of inhaler products including Atrovent, Combivent and Spiriva, used to treat respiratory conditions such as asthma and chronic ...

3. Fact check: Yes, the price of an inhaler in the U.S. is ... - AOL

   www.aol.com/fact-check-yes-price-inhaler...

   Are Americans paying nearly $500 for an inhaler that would cost just $7 overseas? ... Drugs.com “Combivent Respimat Prices, Coupons and Patient Assistance Programs,” accessed Feb. 18, 2024.

4. Yes, the price of an inhaler in the US is massively ... - AOL

   www.aol.com/yes-price-inhaler-us-massively...

   One international pharmaceutical company charges $489 for brand name inhaler Combivent Respimat in the United States but just $7 in France.

5. Ipratropium bromide - Wikipedia

   en.wikipedia.org/wiki/Ipratropium_bromide

   Combination with beta-adrenergic agonists increases the dilating effect on the bronchi, as when ipratropium is combined with salbutamol (albuterol — USAN) under the trade names Combivent (a non-aerosol metered-dose inhaler or MDI) and Duoneb (nebulizer) for the management of COPD and asthma, and with fenoterol (trade names Duovent and ...

6. Ipratropium bromide/salbutamol - Wikipedia

   en.wikipedia.org/wiki/Ipratropium_bromide/salbutamol

   Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD). [1] [4] [5] It contains ipratropium (an anticholinergic) and salbutamol (albuterol, a β 2-adrenergic agonist). [1] Common side effects include sore throat, muscle cramps, and ...

7. Respimat - Wikipedia

   en.wikipedia.org/wiki/Respimat

   Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its developer, Boehringer Ingelheim , is currently [ when? ] conducting approved in the U.S. with a variety of their products, such as tiotropium and ...